SuperC Short Term Plays

[SuperC]

NFRM.017 http://stockcharts.com/h-sc/ui?s=NFRM&p=D&yr=0&mn=3&dy=0&id=p81601781816

52wk .011-1.10

Shares Out approx. 95mil

http://investorshub.advfn.com/boards/board.aspx?board_id=18769

Last 3 news items:

National Pharmaceuticals Lead Therapeutic Drug, GLB333 Application in LupusMarketWire • Wed Apr 6,2011 12:30 AM

National Pharmaceuticals Completes Licensing of GLB333 From Globe LabsMarketWire • Tue Mar 22,2011 4:00 PM

National Pharmaceuticals Corp. in Association With Globe Labs to Enter Into Discussion on Clinical Trials Protocols for GLB333MarketWire • Fri Mar 18,2011 8:05 AM

"National Pharmaceuticals Corp. (PINK SHEETS: NFRM) or the "Company" is pleased to announce that its partner, Globe Laboratories concluded that GLB333, the Company's Lead Therapeutic drug may have effect in the treatment of Lupus. Lupus complications are caused by over expression of certain cytokine (interleukins) according to several scientific reports. The drug GLB333 is an inhibitor of a cytokine that is involved in lupus. Globe Labs has indicated that the drug should be beneficial to treat lupus, due to its inhibitory action on cytokine or interleukin function. There are approximately 1,400,000 lupus patients in the United States according to the Scripps Magazine report (http://www.scripps.edu/philanthropy/lupus.html?origin=ggdislupus). To date there is no effective treatment availed for lupus sufferers. While the actual cause of the disease is not known, but the presence of cytokines or interleukins are well documented.

As you can see from historical, this one can run back up to .04 easily. Any rumor/news on the above items could be fun.

Based on recent volume, .017 to .04ish. Any positive news could easily move this well above .10c and beyond... FYI JMO

SuperC